Exercise + Ibuprofen for Bipolar Depression
Trial Summary
What is the purpose of this trial?
This is a 2x2, within-subjects, cross-over trial to test the anti-depressant effects of acute exercise in 20 participants with bipolar depression. Participants will complete four experimental sessions, two with an exercise challenge and two with a resting control condition in a counterbalanced order. Participants will receive either 800mg of ibuprofen or placebo before exercise or rest in order to test whether blocking the inflammatory response to exercise interferes with the neural and psychological effects of exercise.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking certain medications like those with significant interactions with ibuprofen, immune-modulating medications, or regular NSAIDs more than 3 times a week.
What data supports the effectiveness of the treatment Exercise + Ibuprofen for Bipolar Depression?
Research suggests that exercise can help reduce symptoms of mood disorders like bipolar depression by improving mood stability and increasing cardiorespiratory fitness. Exercise has shown potential benefits in managing bipolar disorder by enhancing neurogenesis (growth of new brain cells) and reducing stress-related damage, which may improve both mental and physical health.12345
Is exercise safe for people with bipolar disorder?
How does the treatment of exercise and ibuprofen differ from other treatments for bipolar depression?
This treatment combines high-intensity interval training (HIIT) with ibuprofen, which is unique because exercise can improve mood and brain function by increasing neurogenesis (growth of new brain cells) and reducing stress, while ibuprofen may help manage inflammation. Unlike standard drug treatments, this approach uses physical activity as a key component to potentially enhance both mental and physical health in bipolar depression.12346
Eligibility Criteria
This trial is for adults aged 18-55 with bipolar depression, a BMI of 18.5-35, and who are stable on medication or deemed appropriate to participate. They must be able to undergo behavioral testing, MRI scans, and blood draws. Exclusions include severe substance abuse, complex psychiatric medication regimens, significant heart conditions or unstable medical issues, pregnancy or breastfeeding without contraception use, metal in the body that affects MRI safety, suicidal tendencies recently or certain medications like NSAIDs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Sessions
Participants complete four experimental sessions, two with an exercise challenge and two with a resting control condition, receiving either ibuprofen or placebo.
Follow-up
Participants are monitored for neural and psychological effects post-intervention
Treatment Details
Interventions
- Acute Exercise
- Ibuprofen
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laureate Institute for Brain Research, Inc.
Lead Sponsor